Join to View Full Profile
825 NE 10th StOupb 2300Oklahoma City, OK 73104
Phone+1 405-271-3445
Dr. Houchen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1993 - 1997
University of MarylandResidency, Internal Medicine, 1990 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1990
Certifications & Licensure
OK State Medical License 2006 - 2025
MO State Medical License 1994 - 2020
Clinical Trials
- Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer Start of enrollment: 2010 Oct 01
- Registry and Fluid Banking of Pancreatic Cystic Lesions Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.Parthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu, Randal May, Nathaniel Weygant
Molecular Cancer. 2025-04-19 - Evolving insights into pancreatic tumor initiation and progression through DCLK1-expressing tuft cells.Landon L Moore, Courtney W Houchen
Developmental Cell. 2025-03-24 - A Novel D-peptide modulates DCLK1 Gelsolin interactions, reducing PDAC tumor growth.Landon L Moore, Dongfeng Qu, Parthasarathy Chandrekesan, Kamille Pitts, Randal May
Research Square. 2025-03-11
Press Mentions
Mason Scientists Receive DOD Funding for Breast Cancer Prevention and Treatment ResearchMarch 15th, 2022
Trigger for Muscle-Wasting Condition DiscoveredJune 12th, 2019
Cancer Stem Cells Isolated: Could Lead to New Drugs to Stop Cancer from ReturningSeptember 12th, 2008
Grant Support
- Molecular targeting of DCLK1 signaling in hepatocellular carcinomaOKLAHOMA CITY VA MEDICAL CENTER2017–2026
- Addressing Health Disparities among Oklahoma Minority and Rural Communities through Clinical Research Education and Career DevelopmentUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR2017–2025
- Pancreatic Stem Cells And CancerNational Cancer Institute2010–2011
- Isolation And Characterization Of Intestinal Stem Cells Using Novel Markers (RP)National Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Prostaglandins And Gastrointestinal DNA DamageNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Prostaglandins And Gastrointestinal DNA DamageNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Prostaglandin E2 Receptors In Gastrointestinal InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
